Genocea Biosciences Financials
| GNCADelisted Stock | USD 0.0002 0.0001 100.00% |
Genocea |
Understanding current and past Genocea Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Genocea Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Genocea Biosciences' assets may result in an increase in income on the income statement.
Please note, the presentation of Genocea Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Genocea Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Genocea Biosciences' management manipulating its earnings.
Genocea Biosciences Stock Summary
Genocea Biosciences competes with Parker Hannifin, Eldorado Gold, Barrick Gold, Gatos Silver, and Denison Mines. Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Genocea Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 74 people.| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US3724274010 |
| Business Address | 100 Acorn Park |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.genocea.com |
| Phone | 617 876 8191 |
| Currency | USD - US Dollar |
Genocea Biosciences Key Financial Ratios
Genocea Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genocea Biosciences's current stock value. Our valuation model uses many indicators to compare Genocea Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genocea Biosciences competition to find correlations between indicators driving Genocea Biosciences's intrinsic value. More Info.Genocea Biosciences is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genocea Biosciences' earnings, one of the primary drivers of an investment's value.Genocea Biosciences Market Pulse
| Quote | 2.0E-4 |
| Change(%) | 100.00 |
| Change | 0.0001 |
| Open | 1.0E-4 |
| Low | 1.0E-4 |
| High | 2.0E-4 |
| Volume | 0 |
| Exchange | NASDAQ |
About Genocea Biosciences Financials
What exactly are Genocea Biosciences Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Genocea Biosciences' income statement, its balance sheet, and the statement of cash flows. Potential Genocea Biosciences investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Genocea Biosciences investors may use each financial statement separately, they are all related. The changes in Genocea Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Genocea Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Genocea Stock
If you are still planning to invest in Genocea Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genocea Biosciences' history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |